课题基金 / 基金详情

Amelioration of hepatic ischemia/reperfusion injury by ischemic preconditioning

Amelioration of hepatic ischemia/reperfusion injury by ischemic preconditioning
缺血预处理改善肝脏缺血/再灌注损伤
批准号:
08671376
负责人:
YANAGA Katsuhiko
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998

项目摘要

项目成果

YANAGA Katsuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
[Background]Ischemic preconditioning, i.e. preparatory brief ischemia before subsequent long ischemia, protects canine heart from myocardial injury caused by long ischemia (Circulation 1986). We have reported the protective effect of ischemic preconditioning in the liver. To our knowledge, however, little has known about the mechanisms of ischemic preconditioning.[Purpose]The prupose of this study was to clarify the mechanisms of ischemic preconditioning in rat hepatic warm ischemia/reperfusion model and demonstrate the same phenomenon in rat liver transplantation.[results](1) Murry et al. proposed that the mechanism for protection of the myocardium in ischemic preconditioning includes reduced myocardial energy demand which results in reduced utilization of high-energy phosphate and preservation of ATP, In this study, at 120 min after reperfusion following 40min of warm ischemia, the livers with 10 min of ischemic preconditioning had a significantly higher ATP level than the control livers (78*13% versus 61*11%, p<0.05). (2) Next, we performed orthotopic liver transplantation in rats. In this setting, liver grafts were preserved in UW solution for 1, 12, or 24 hr at 4゚C with or without 10 min of ischemic preconditioning. Liver grafts with ischemic preconditioning had no significant improvement in AST or ALT at 4 hr after reperfusion. Survival study and histological examination had also no significant change in both groups. We could not demonstrate the same phenomenon in our transplantation model.[discussion]This study has demonstrated for the first time the advantage of ischemic preconditioning on hepatic warm ischemia/reperfusion injury in rats. The recovery of tissue ATP may be associated with the protective effect of ischemic preconditioning. What seems to be a paradoxical phenomenon may be useful for the amelioration of hepatic ischemia/reperfusion injury in liver surgery.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Yoshizumi T: "Amelioration of liver injury by ischaemic preconditioning" Br J Surg. 85. 1636-1640 (1998)
Yoshizumi T:“通过缺血预处理改善肝损伤”Br J Surg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Soejima Y: "Effect of thoromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation" Surgery. 123. 67-72 (1998)
Soejima Y:“Thoromboxane 合成酶抑制剂对大鼠原位肝移植中无心跳供体的影响”手术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Development of implantable artificial liver and hepatic transformation of the kidney for treatment of chronic liver diseases
  • 批准号:
    18390371
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.95万
  • 财政年份:
    2006
  • 负责人:
    YANAGA Katsuhiko
  • 依托单位:
国内基金
海外基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张明
  • 依托单位:
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
  • 批准号:
    82371301
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李轶
  • 依托单位:
TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
  • 批准号:
    82371142
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    刘君
  • 依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题